Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Bill & Melinda Gates Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Arsanis Raises USD45.5 Million in Series D Financing 15
Kymab Raises USD100.5 Million in Series C Financing 17
Just Biotherapeutics Raises USD14 Million in Series A2 Financing 19
Affinivax Raises USD2.5 Million in Venture Financing 21
Lodo Therapeutics Raises USD17 Million in Series A Financing 22
Atreca Raises USD56 Million in Series A Financing 24
CureVac to Raise USD76 Million in Venture Financing 25
Affinivax Raises USD4 Million in Seed Venture Financing 26
Synlogic Raises Additional USD5 Million in Series A Venture Financing 27
Kymab Raises USD40 Million in Series B Financing 28
Visterra Raises US$8.1 Million In Extended Series A Financing 29
Visterra Raises Additional US$13 Million In Series A Financing 31
Genocea Biosciences Raises US$30 Million In Series C Financing 33
Partnerships 35
CureVac to Enter into Development Agreement with Bill & Melinda Gates 35
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 36
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 37
Anacor Pharma Ammends its Research Agreement With Bill & Melinda Gates Foundation 38
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 39
Equity Offering 40
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 40
CureVac Raises USD110 Million in Private Placement of Shares 41
Bill & Melinda Gates Foundation – Key Competitors 42
Bill & Melinda Gates Foundation – Key Employees 43
Bill & Melinda Gates Foundation – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 44
Recent Developments 45
Government and Public Interest 45
Nov 29, 2017: Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin 45
Oct 23, 2017: Ventria Bioscience aids global fight against intestinal infections that threaten up to 400 million children a year 46
Aug 18, 2017: IHI Partners with South Africa National Department of Health on Initiative to Improve Tuberculosis Care and Outcomes 47
Jun 12, 2017: Rotary and the Bill & Melinda Gates Foundation announce $450 million commitment to end polio 48
Mar 06, 2017: Vaxess Technologies Receives Grants Totaling $6 Million to Develop Microneedle Vaccines for Polio, Measles, Rubella 49
Jan 09, 2017: Kymab expands Infectious Disease Programmes 50
Dec 02, 2016: Access Bio recieved a USD $3.7 million grant from the Bill & Melinda Gates Foundation 51
Oct 19, 2016: Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection 52
Oct 18, 2016: Gates Foundation Awards $1.1 Million Grant for MediBeacon Collaboration with Washington University 53
Jun 09, 2016: Batavia Biosciences Receives Grant from the Bill & Melinda Gates Foundation to Support Vaccine Availability in Developing Count 54
May 26, 2016: EnBiotix, Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 55
Jan 18, 2016: Evestra Receives Gates Foundation Grant 56
Jan 12, 2016: Moderna Therapeutics, Through Valera, its Infectious Disease Venture, Announces Initial Grant of up to $20 Million to Advance mRNA-Based Antibody Combination to Help Prevent HIV Infection 57
Product News 58
Jul 20, 2016: Penn-led team develops plant-based Polio booster vaccine 58
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Bill & Melinda Gates Foundation, Deals By Therapy Area, 2011 to YTD 2017 9
Bill & Melinda Gates Foundation, Medical Devices Deals, 2011 to YTD 2017 10
Bill & Melinda Gates Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Visterra Raises Additional USD23.6 Million in Series C Financing 13
Arsanis Raises USD45.5 Million in Series D Financing 15
Kymab Raises USD100.5 Million in Series C Financing 17
Just Biotherapeutics Raises USD14 Million in Series A2 Financing 19
Affinivax Raises USD2.5 Million in Venture Financing 21
Lodo Therapeutics Raises USD17 Million in Series A Financing 22
Atreca Raises USD56 Million in Series A Financing 24
CureVac to Raise USD76 Million in Venture Financing 25
Affinivax Raises USD4 Million in Seed Venture Financing 26
Synlogic Raises Additional USD5 Million in Series A Venture Financing 27
Kymab Raises USD40 Million in Series B Financing 28
Visterra Raises US$8.1 Million In Extended Series A Financing 29
Visterra Raises Additional US$13 Million In Series A Financing 31
Genocea Biosciences Raises US$30 Million In Series C Financing 33
CureVac to Enter into Development Agreement with Bill & Melinda Gates 35
Sanofi Pasteur Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 36
GSK Enters Into Agreement With Bill & Melinda Gates Foundation To Discover Vaccines 37
Anacor Pharma Ammends its Research Agreement With Bill & Melinda Gates Foundation 38
Atreca Enters into Agreement with Bill & Melinda Gates Foundation 39
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 40
CureVac Raises USD110 Million in Private Placement of Shares 41
Bill & Melinda Gates Foundation, Key Competitors 42
Bill & Melinda Gates Foundation, Key Employees 43
Bill & Melinda Gates Foundation, Other Locations 44
Bill & Melinda Gates Foundation, Joint Venture 44